American Research & Management Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$977K Sell
3,658
-335
-8% -$89.5K 0.27% 66
2022
Q2
$814K Sell
3,993
-596
-13% -$121K 0.21% 75
2022
Q1
$966K Sell
4,589
-355
-7% -$74.7K 0.21% 72
2021
Q4
$1.19M Sell
4,944
-1,095
-18% -$263K 0.26% 66
2021
Q3
$1.71M Sell
6,039
-410
-6% -$116K 0.39% 58
2021
Q2
$2.23M Sell
6,449
-202
-3% -$69.9K 0.51% 52
2021
Q1
$1.86M Sell
6,651
-140
-2% -$39.2K 0.45% 55
2020
Q4
$1.66M Sell
6,791
-100
-1% -$24.5K 0.43% 55
2020
Q3
$1.96M Sell
6,891
-39
-0.6% -$11.1K 0.57% 49
2020
Q2
$1.85M Hold
6,930
0.56% 48
2020
Q1
$2.19M Sell
6,930
-100
-1% -$31.6K 0.83% 39
2019
Q4
$2.09M Sell
7,030
-1,725
-20% -$512K 0.62% 47
2019
Q3
$2.04M Sell
8,755
-1,315
-13% -$306K 0.61% 45
2019
Q2
$2.36M Sell
10,070
-320
-3% -$74.8K 0.7% 40
2019
Q1
$2.46M Hold
10,390
0.7% 38
2018
Q4
$3.13M Sell
10,390
-25
-0.2% -$7.52K 1.05% 30
2018
Q3
$3.68M Buy
10,415
+60
+0.6% +$21.2K 1.09% 28
2018
Q2
$3.01M Buy
10,355
+1,145
+12% +$332K 1.04% 29
2018
Q1
$2.52M Buy
9,210
+110
+1% +$30.1K 0.83% 35
2017
Q4
$2.9M Buy
9,100
+65
+0.7% +$20.7K 0.89% 34
2017
Q3
$2.83M Buy
9,035
+85
+0.9% +$26.6K 0.92% 35
2017
Q2
$2.43M Buy
8,950
+125
+1% +$33.9K 0.8% 39
2017
Q1
$2.41M Buy
8,825
+950
+12% +$260K 0.86% 36
2016
Q4
$2.23M Sell
7,875
-40
-0.5% -$11.3K 0.76% 39
2016
Q3
$2.48M Buy
7,915
+1,100
+16% +$344K 0.9% 35
2016
Q2
$1.65M Buy
6,815
+1,890
+38% +$457K 0.63% 48
2016
Q1
$1.28M Buy
4,925
+680
+16% +$177K 0.54% 52
2015
Q4
$1.3M Buy
4,245
+1,985
+88% +$608K 0.56% 52
2015
Q3
$659K Buy
2,260
+1,990
+737% +$580K 0.29% 73
2015
Q2
$109K Hold
270
0.04% 131
2015
Q1
$114K Sell
270
-30
-10% -$12.7K 0.05% 126
2014
Q4
$102K Hold
300
0.04% 130
2014
Q3
$99K Hold
300
0.04% 140
2014
Q2
$95K Hold
300
0.03% 141
2014
Q1
$92K Hold
300
0.03% 137
2013
Q4
$84K Hold
300
0.03% 144
2013
Q3
$72K Hold
300
0.03% 147
2013
Q2
$65K Buy
+300
New +$65K 0.03% 154